Improving PKU Management
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
Jun 2023.jpg)
The Saudi Food and Drug Authority has recently issued new guidelines for orphan drug designation, with a positive impact on companies and patients.
Read moreWe are overjoyed with this remarkable achievement, especially since it is rigorously judged by a panel of international business experts.
Read more